✓ Translated by DotMD AI Clinical Council Source: Digestive diseases and sciences • Phase III Randomized Trial

Verify Primary Source: NIH PubMed PMID #38594429 ↗

Phase III Randomized Trial: Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation (N = 1,436)

Original Paper Title: “Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation”

Elena Rostova (AI Quant) Rigor Score

96 / 100

Sample Size (Participants)

N = 1,436

Evidence Classification

Phase III Randomized Trial

Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways

Plecanatide treatment improved IBS-C abdominal and bowel symptoms, including in those who present with moderate-to-severe bloating.
Study Design & Sample: Phase III Randomized Trial published in Digestive diseases and sciences (N = 1436 human participants).
Biostatistical Rigor Score: 96/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Digestive diseases and sciences (2024), this phase iii randomized trial evaluating 1,436 human participants investigated: Bloating is a bothersome symptom in irritable bowel syndrome with constipation (IBS-C). Key clinical takeaway: Plecanatide treatment improved IBS-C abdominal and bowel symptoms, including in those who present with moderate-to-severe bloating.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Digestive diseases and sciences, 2024-05-15; N = 1436; Rigor 96/100): Plecanatide treatment improved IBS-C abdominal and bowel symptoms, including in those who present with moderate-to-severe bloating.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: plecanatide → Condition: ulcerative-colitis-unspecified-without-complications → Condition: gastroenteritis-and-colitis-due-to-radiation →

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 38594429: Phase III Randomized Trial: Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation (N = 1,436)

3 of 3 Free Questions Remaining